Summary
patients treated
Has anyone ever benefited from stem cell?
For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.
FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.
List of patients
| No. | Source | Source type | Diagnosis | Medical sector | Year of application | Therapy | Country | Age of the recipient |
|---|---|---|---|---|---|---|---|---|
| 6401 | Cord Tissue | Allogeneic – Unrelated | Spinocerebellar Ataxia | Neurology | 2015 | Experimental Therapy | Poland | 44,6 |
| 6402 | Cord Tissue | Allogeneic – Unrelated | Spinocerebellar Ataxia | Neurology | 2015 | Experimental Therapy | Poland | 24,3 |
| 6403 | Cord Tissue | Allogeneic – Unrelated | Stroke | Neurology | 2015 | Experimental Therapy | Poland | 62,8 |
| 6404 | Cord Tissue | Allogeneic – Unrelated | Stroke | Neurology | 2015 | Experimental Therapy | Poland | 54,9 |
| 6405 | Cord Tissue | Allogeneic – Unrelated | Traumatic Encephalopathy | Neurology | 2015 | Experimental Therapy | Poland | 20,11 |
| 6406 | Cord Blood | Allogeneic – Related | Acute Lymphoblastic Leukemia | Hematology | 2015 | Standard Therapy | Poland | 4 |
| 6407 | Cord Blood | Autologous | Brain Damage | Neurology | 2015 | Experimental Therapy | Germany | 5 |
| 6408 | Cord Blood | Autologous | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2015 | Experimental Therapy | UK | 6 months |
| 6409 | Cord Blood | Autologous | Neuroblastoma | Hematology | 2015 | Standard Therapy | Germany | 5 |
| 6410 | Cord Blood | Allogeneic – Related | Scid (Severe Combined Immunodeficiency) | Hematology | 2015 | Standard Therapy | UK | 3 months |
| 6411 | Cord Blood | Allogeneic – Related | Sickle Cell Anemia | Hematology | 2015 | Standard Therapy | UK | 2,6 |
| 6412 | Cord Blood | Allogeneic – Related | Thalassemia | Hematology | 2015 | Standard Therapy | UK | 12 |
| 6413 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2015 | Standard Therapy | Turkey | 3 |
| 6414 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2015 | Standard Therapy | Turkey | 2 |
| 6415 | Bone Marrow Family | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2015 | Standard Therapy | Germany | 74 |
| 6416 | Bone Marrow Family | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 64 |
| 6417 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2015 | Standard Therapy | Germany | 23 |
| 6418 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 72 |
| 6419 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 43 |
| 6420 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 63 |
| 6421 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 73 |
| 6422 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 61 |
| 6423 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 33 |
| 6424 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 42 |
| 6425 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 57 |
| 6426 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 37 |
| 6427 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 72 |
| 6428 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 63 |
| 6429 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 66 |
| 6430 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 45 |
| 6431 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 48 |
| 6432 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 59 |
| 6433 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 58 |
| 6434 | Apheresis | Autologous | Anaplastic Large Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 57 |
| 6435 | Apheresis | Autologous | Anaplastic T-Cell Lymphoma – Relapse | Hematology | 2015 | Standard Therapy | Germany | 26 |
| 6436 | Apheresis | Allogeneic | Aplastic Anemia – Relapse | Hematology | 2015 | Standard Therapy | Germany | 53 |
| 6437 | Apheresis | Allogeneic | B-Cell Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 59 |
| 6438 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 48 |
| 6439 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 23 |
| 6440 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 62 |
| 6441 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2015 | Standard Therapy | Germany | 51 |
| 6442 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2015 | Standard Therapy | Germany | 50 |
| 6443 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 31 |
| 6444 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 57 |
| 6445 | Apheresis | Autologous | Ewing Sarcoma | Hematology | 2015 | Standard Therapy | Germany | 24 |
| 6446 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2015 | Standard Therapy | Germany | 17 |
| 6447 | Apheresis | Autologous | Gray Zone Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 26 |
| 6448 | Apheresis | Autologous | Hodgkin Relapse | Hematology | 2015 | Standard Therapy | Germany | 29 |
| 6449 | Apheresis | Autologous | Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 53 |
| 6450 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 56 |
| 6451 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 66 |
| 6452 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 53 |
| 6453 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 63 |
| 6454 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 58 |
| 6455 | Apheresis | Autologous | Mantle Cell Lymphoma-Relapse | Hematology | 2015 | Standard Therapy | Germany | 66 |
| 6456 | Apheresis | Allogeneic | Morbus Hodgkin | Hematology | 2015 | Standard Therapy | Germany | 25 |
| 6457 | Apheresis | Allogeneic | Morbus Hodgkin | Hematology | 2015 | Standard Therapy | Germany | 22 |
| 6458 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 58 |
| 6459 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 54 |
| 6460 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 62 |
| 6461 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 70 |
| 6462 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 69 |
| 6463 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 56 |
| 6464 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 75 |
| 6465 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 70 |
| 6466 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 60 |
| 6467 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 72 |
| 6468 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 56 |
| 6469 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 65 |
| 6470 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 37 |
| 6471 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 54 |
| 6472 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 29 |
| 6473 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 68 |
| 6474 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 50 |
| 6475 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 61 |
| 6476 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 69 |
| 6477 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 60 |
| 6478 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 72 |
| 6479 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 43 |
| 6480 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 53 |
| 6481 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 73 |
| 6482 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 66 |
| 6483 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 61 |
| 6484 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 70 |
| 6485 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 71 |
| 6486 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 62 |
| 6487 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 56 |
| 6488 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 74 |
| 6489 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 50 |
| 6490 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 51 |
| 6491 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 63 |
| 6492 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 53 |
| 6493 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 72 |
| 6494 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 48 |
| 6495 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 63 |
| 6496 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 60 |
| 6497 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 65 |
| 6498 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 71 |
| 6499 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 61 |
| 6500 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 61 |